Table 2 The concentrations of antitumor drugs used in the MTT experiments.
Antitumor drugs | Concentrations (μmol/L) | |||||||
|---|---|---|---|---|---|---|---|---|
TKIs | sorafenib | 10.000 | 3.000 | 1.000 | 0.300 | 0.100 | 0.030 | 0.010 |
lenvatinib | 10.000 | 3.000 | 1.000 | 0.300 | 0.100 | 0.030 | 0.010 | |
regorafenib | 10.000 | 3.000 | 1.000 | 0.300 | 0.100 | 0.030 | 0.010 | |
cabozantinib | 10.000 | 3.000 | 1.000 | 0.300 | 0.100 | 0.030 | 0.010 | |
Chemotherapies | doxorubicin | 1.000 | 0.300 | 0.100 | 0.030 | 0.010 | 0.003 | 0.001 |
paclitaxel | 0.300 | 0.100 | 0.030 | 0.010 | 0.003 | 0.001 | 0.000 | |
etoposide | 1.000 | 0.300 | 0.100 | 0.030 | 0.010 | 0.003 | 0.001 | |
irinotecan | 3.000 | 1.000 | 0.300 | 0.100 | 0.030 | 0.010 | 0.003 | |
